Journal of Lipid Research, Vol 21, 238-249, Copyright © 1980 by Lipid Research, Inc.

ARTICLES

Kinetic studies of the transfer of esterified cholesterol between human plasma low and high density lipoproteins

PJ Barter and ME Jones

In vitro incubations (6 hr at 37 degrees C) of human low density lipoproteins (LDL), high density lipoproteins (HDL), and lipoprotein- free plasma revealed no significant net mass transfers of esterified cholesterol from either lipoprotein fraction to the other. Transfers of esterified [3H]cholesterol from LDL to HDL must therefore have represented a process of molecular exchange between the two fractions. In molar terms, the exchange increased with increasing incubation concentrations of LDL regardless of whether the HDL was increased in parallel, decreased, or kept constant. In direct contrast, with LDL kept constant, an increase in the concentration of HDL resulted in a decrease in the molar rate of exchange of esterified cholesterol between LDL and HDL. The data were then fitted to a mathematical model describing a physical model in which an esterified cholesterol transfer protein circulates in the plasma, interacting with lipoprotein particles into which it deposits and from which it picks up esterified cholesterol molecules. According to this model, to which the experimental data fit extremely well, the transfer protein had a much greater affinity for HDL than for LDL in a transfer process that was readily saturable by HDL but not by LDL.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. W. Clark, R. B. Ruggeri, D. Cunningham, and M. J. Bamberger Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action J. Lipid Res., March 1, 2006; 47(3): 537 - 552. [Abstract] [Full Text] [PDF]

				L. Dumont, T. Gautier, J.-P. P. de Barros, H. Laplanche, D. Blache, P. Ducoroy, J. Fruchart, J.-C. Fruchart, P. Gambert, D. Masson, et al. Molecular Mechanism of the Blockade of Plasma Cholesteryl Ester Transfer Protein by Its Physiological Inhibitor Apolipoprotein CI J. Biol. Chem., November 11, 2005; 280(45): 38108 - 38116. [Abstract] [Full Text] [PDF]

				T. Gautier, D. Masson, M. C. Jong, L. Duverneuil, N. Le Guern, V. Deckert, J.-P. P. de Barros, L. Dumont, A. Bataille, Z. Zak, et al. Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice J. Biol. Chem., August 23, 2002; 277(35): 31354 - 31363. [Abstract] [Full Text] [PDF]

				M. S. Gowri, D. R. Van der Westhuyzen, S. R. Bridges, and J. W. Anderson Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2226 - 2233. [Abstract] [Full Text] [PDF]

				J. Huuskonen, G. Wohlfahrt, M. Jauhiainen, C. Ehnholm, O. Teleman, and V. M. Olkkonen Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis J. Lipid Res., June 1, 1999; 40(6): 1123 - 1130. [Abstract] [Full Text]

				D. Masson, N. Duverger, F. Emmanuel, and L. Lagrost Differential Interaction of the Human Cholesteryl Ester Transfer Protein with Plasma High Density Lipoproteins (HDLs) from Humans, Control Mice, and Transgenic Mice to Human HDL Apolipoproteins. LACK OF LIPID TRANSFER INHIBITORY ACTIVITY IN TRANSGENIC MICE EXPRESSING HUMAN apoA-I J. Biol. Chem., September 26, 1997; 272(39): 24287 - 24293. [Abstract] [Full Text] [PDF]

				K.-A. Rye, N. J. Hime, and PhilipJ. Barter Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion J. Biol. Chem., February 14, 1997; 272(7): 3953 - 3960. [Abstract] [Full Text] [PDF]

				R. McPherson, P. Lau, P. Kussie, H. Barrett, and A. R. Tall Plasma Kinetics of Cholesteryl Ester Transfer Protein in the Rabbit: Effects of Dietary Cholesterol Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 203 - 210. [Abstract] [Full Text]

				G. W. Melchior, K. A. Greenlee, C. K. Castle, M. J. Prough, R. W. Milne, K. R. Marotti, and F. J. Kezdy Evidence That Cynomolgus Monkey Cholesteryl Ester Transfer Protein Has Two Neutral Lipid Binding Sites J. Biol. Chem., September 8, 1995; 270(36): 21068 - 21074. [Abstract] [Full Text] [PDF]

				L. Lagrost, E. Florentin, V. Guyard-Dangremont, A. Athias, H. Gandjini, C. Lallemant, and P. Gambert Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1388 - 1396. [Abstract] [Full Text]

				S. Wang, P. Kussie, L. Deng, and A. Tall Defective Binding of Neutral Lipids by a Carboxyl-terminal Deletion Mutant of Cholesteryl Ester Transfer Protein J. Biol. Chem., January 13, 1995; 270(2): 612 - 618. [Abstract] [Full Text] [PDF]

				K.-A. Rye, N. J. Hime, and P. J. Barter The Influence of Cholesteryl Ester Transfer Protein on the Composition, Size, and Structure of Spherical, Reconstituted High Density Lipoproteins J. Biol. Chem., January 6, 1995; 270(1): 189 - 196. [Abstract] [Full Text] [PDF]

				T. Gautier, D. Masson, J.-P. P. de Barros, A. Athias, P. Gambert, D. Aunis, M.-H. Metz-Boutigue, and L. Lagrost Human Apolipoprotein C-I Accounts for the Ability of Plasma High Density Lipoproteins to Inhibit the Cholesteryl Ester Transfer Protein Activity J. Biol. Chem., November 22, 2000; 275(48): 37504 - 37509. [Abstract] [Full Text] [PDF]